(PharmaNewsWire.Com, October 07, 2017 ) ReportsWeb.com published “Non-Alcoholic Steatohepatitis Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Original Content:
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2017, provides an overview of the Non-Alcoholic Steatohepatitis (Gastrointestinal) pipeline landscape.
Non-alcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. NASH can get worse and cause scarring of the liver, which leads to cirrhosis. Symptoms of NASH include fatigue, weight loss for no clear reason, general weakness and an ache in the upper right part of belly. Risk factors include obesity, type 2 diabetes, high cholesterol and high triglycerides and metabolic syndrome.
Publisher's Pharmaceutical and Healthcare latest pipeline guide Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Non-Alcoholic Steatohepatitis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Non-Alcoholic Steatohepatitis (Basal Cell Nevus Syndrome) (Genetic Disorders). - The pipeline guide reviews pipeline therapeutics for Non-Alcoholic Steatohepatitis (Basal Cell Nevus Syndrome) (Genetic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Non-Alcoholic Steatohepatitis (Basal Cell Nevus Syndrome) (Genetic Disorders) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Non-Alcoholic Steatohepatitis (Basal Cell Nevus Syndrome) (Genetic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Non-Alcoholic Steatohepatitis (Basal Cell Nevus Syndrome) (Genetic Disorders). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Non-Alcoholic Steatohepatitis (Basal Cell Nevus Syndrome) (Genetic Disorders) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. Companies Mentioned: Nitto Denko Corp Novartis AG NovaTarg Therapeutics Inc Novo Nordisk A/S Nuevolution AB Pfizer Inc Pharmaxis Ltd Promethera Biosciences SA ProMetic Life Sciences Inc Protalix BioTherapeutics Inc Regulus Therapeutics Inc Saje Pharma LLC Sancilio & Company Inc Shire Plc Stelic Institute & Co Inc TaiwanJ Pharmaceuticals Co Ltd Tiziana Life Sciences Plc TRACON Pharmaceuticals Inc Vascular Biogenics Ltd Verlyx Pharma Inc Viking Therapeutics Inc Virobay Inc Zydus Cadila Healthcare Ltd
About ReportsWeb: ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: